CalciMedica, Inc. — Investor Relations & Filings
CalciMedica, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapies for acute inflammatory and immunologic diseases. The company specializes in the inhibition of calcium release-activated calcium (CRAC) channels, a therapeutic approach designed to modulate the immune response and protect against tissue cell injury. Its lead product candidate, Auxora™, is an intravenous formulation of the proprietary small molecule CRAC channel inhibitor, zegocractin. CalciMedica is developing Auxora for the treatment of life-threatening conditions with high unmet medical needs, including acute kidney injury (AKI) with respiratory failure and acute pancreatitis (AP), for which there are currently no approved disease-modifying treatments.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - CalciMedica, Inc. (0001534133) (Filer) | 2026-05-12 | English | |
| 10-K/A - CalciMedica, Inc. (0001534133) (Filer) | 2026-04-30 | English | |
| S-3 - CALCIMEDICA, INC. (0001534133) (Filer) | 2026-03-03 | English | |
| 10-K - CALCIMEDICA, INC. (0001534133) (Filer) | 2026-03-03 | English | |
| 8-K - CALCIMEDICA, INC. (0001534133) (Filer) | 2026-03-03 | English | |
| SCHEDULE 13G/A Filing | 2026-02-06 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
8 filings
| |||||
| 45231608 | 8-K - CalciMedica, Inc. (0001534133) (Filer) | 2026-05-12 | English | ||
| 39208161 | 10-K/A - CalciMedica, Inc. (0001534133) (Filer) | 2026-04-30 | English | ||
| 32893525 | S-3 - CALCIMEDICA, INC. (0001534133) (Filer) | 2026-03-03 | English | ||
| 32893526 | 10-K - CALCIMEDICA, INC. (0001534133) (Filer) | 2026-03-03 | English | ||
| 32893524 | 8-K - CALCIMEDICA, INC. (0001534133) (Filer) | 2026-03-03 | English | ||
| 30430142 | SCHEDULE 13G/A Filing | 2026-02-06 | English | ||
| 30430167 | 8-K Filing | 2026-01-28 | English | ||
| 30430145 | 8-K Filing | 2026-01-28 | English | ||
|
2025
7 filings
| |||||
| 12507329 | Major Shareholding Notification 2025 | 2025-12-01 | English | ||
| 12507327 | 10-Q | 2025-11-12 | English | ||
| 12507326 | 8-K | 2025-11-12 | English | ||
| 12507328 | Major Shareholding Notification 2025 | 2025-11-07 | English | ||
| 12507330 | 8-K | 2025-11-06 | English | ||
| 12507332 | 424B5 | 2025-11-06 | English | ||
| 12507334 | Major Shareholding Notification 2025 | 2025-10-29 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
89bio, Inc.
Clinical-stage biopharma developing therapies for liver and…
|
ETNB | US | Manufacturing |
|
Aardvark Therapeutics, Inc.
Clinical-stage biopharma developing therapeutics for hunger…
|
AARD | US | Manufacturing |
|
Aarey Drugs & Pharmaceuticals Ltd
Manufactures APIs and chemical intermediates for global pha…
|
AAREYDRUGS | IN | Manufacturing |
|
Aarti Drugs Limited
Produces APIs, pharma intermediates, and specialty chemical…
|
AARTIDRUGS | IN | Manufacturing |
|
Aarti Pharmalabs Limited
Manufacturer of APIs, intermediates, and xanthines with glo…
|
AARTIPHARM | IN | Manufacturing |
|
AAYUSH WELLNESS LIMITED
Develops and markets herbal formulations, supplements, and …
|
539528 | IN | Manufacturing |
|
Ab&B Bio-Tech CO., LTD. JS
Biopharmaceutical company engaged in the R&D and commercial…
|
2627 | HK | Manufacturing |
|
Abbisko Cayman Limited
Clinical-stage biopharma focused on discovering and develop…
|
2256 | KY | Manufacturing |
|
Abbott India Ltd.
Provides pharmaceutical solutions in gastroenterology, card…
|
ABBOTINDIA | IN | Manufacturing |
|
ABBOTT LABORATORIES
Global healthcare company in medical devices, diagnostics, …
|
ABT | US | Manufacturing |
CalciMedica, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34649/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34649 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34649 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34649 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34649}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for CalciMedica, Inc. (id: 34649)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.